PET/MR Imaging In Patients With Cardiac Amyloidosis

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

February 6, 2020

Study Completion Date

February 6, 2020

Conditions
Cardiac Amyloidosis
Interventions
OTHER

18F-NaF PET

Hybrid 18F-NaF PET/MR imaging for observational diagnostic purposes

Trial Locations (1)

EH16 4TJ

Queen's Medical Research Institute, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT03626584 - PET/MR Imaging In Patients With Cardiac Amyloidosis | Biotech Hunter | Biotech Hunter